Orlando Clinical Research Center ( Site 0002)

Orlando, Florida 32809

1 studies enrolling now · 9 studies all time

What they study most

Antibacterial Agents, Chronic Kidney Failure, End-Stage Kidney Disease, End-Stage Renal Disease, Healthy, Healthy Participants, Hepatic Impairment, Hepatic Insufficiency, Kidney Failure, Chronic, Renal Dialysis, Renal Failure, Chronic, Renal Failure, End-Stage

Studies at this site

• A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006) — Recruiting now
• A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030) — Completed
• A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010) — Completed
• A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010) — Completed
• Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004) — Completed
• The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026) — Completed
• Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386) — Completed
• Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006) — Stopped early
• Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005) — Completed